Hubbry Logo
HeraeusHeraeusMain
Open search
Heraeus
Community hub
Heraeus
logo
7 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Heraeus
Heraeus
from Wikipedia

Heraeus is a German technology group with a focus on precious and special metals, medical technology, quartz glass and sensors as well as electronic components. Founded in Hanau in 1851, the company is one of the largest family-owned companies in Germany in terms of revenue.[4][5] Heraeus employs 16,400 people in 40 countries and generated a total revenue of €25.6 billion in 2023. The headquarters and head office are in Hanau, Germany.[2][3]

Key Information

History

[edit]

1660: Pharmacy as the origin of the group

[edit]

The origins of the Heraeus family business go back to the 17th century. In October 1660, Isaac Heraeus (1636-1676) took over what was then the Faucque pharmacy in Hanau-Neustadt, east of Frankfurt. In 1668, he opened his own pharmacy on the market square in Hanau-Neustadt under the name "Zum weißen Einhorn", which later became the Einhorn Pharmacy.[6][7] The Einhorn Pharmacy was run as a count's court pharmacy for a total of six generations until the middle of the 19th century.[7]

1851 – 1888: Founding of the platinum smelter

[edit]
The Einhorn Pharmacy in Hanau

Since the end of the 18th century, Hanau was a town of goldsmiths and platinum had been processed in the town for the production of jewelry. Goldsmiths had extreme difficulty processing platinum due to its toughness and high melting point of 1770 degrees Celsius. Until a melting process was discovered, platinum could only be processed by using complex forging processes using the white-hot metal. In 1851, at the age of 24, the pharmacist and chemist Wilhelm Carl Heraeus took over the Einhorn Pharmacy from his father Esay Heraeus (1785-1830).[8][9]

Heraeus understood the problems faced by goldsmiths. After a series of experiments, he first succeeded in melting platinum in large volumes and producing pure metal in 1856, using an oxyhydrogen blowpipe he developed himself.[5][9] Although the process was already known, this had previously only succeeded in small quantities in the laboratory. With his gas blowpipe, Heraeus could produce enough oxyhydrogen and a large enough flame front to melt several kilograms of platinum-containing materials.[9]

This enabled Heraeus to found the W.C. Heraeus First German Platinum Smelters, supplying a variety of customers such as goldsmith workshops and jewelry factories internationally, as well as dental manufacturers, chemistry laboratories and other branches of industry. In 1857, W.C. Heraeus succeeded in producing around 30 kilograms of pure platinum.[9] Between 1875 and 1879, up to 400 kilograms were sold per year, and in 1888, over 900 kilograms.[10]

Crucibles made of platinum and quartz

1889 – 1926: Inventions and patents

[edit]
Richard Küch

In 1889, the two sons of the company founder, Wilhelm and Heinrich Heraeus, took over the management.[11] Research and development was further pursued, and the physicist and chemist Richard Küch, a former school friend of the Heraeus brothers, joined the company in 1890. Küch's research resulted in the German Imperial Patent No. 63591 in 1891 for the gilding of platinum sheet, the first patent in the company's history. Küch then developed a process by which quartz glass could be obtained by melting rock crystal at around 2000 °C.[12][13]

The quartz glass produced by the company was almost entirely free of defects and was of outstanding purity. It is still used in medicine and is a highly sought-after material in manufacturing on account of its translucence and resistance to heat and acids. With the advent of ceramic colors, more platinum was needed for production processes, and Heraeus started supplying products to the electrochemical and plastics industries. As the company continued to expand, it needed new premises – so in 1896, the W.C. Heraeus Platinum Smelting Factory was established just outside Hanau, employing 40 people.[13]

Further experimentation in the platinum smelters’ laboratories resulted in a variety of inventions and new production processes. These included the production of pharmaceutical iron compounds, chemically pure hydrofluoric acid, rubidium, and caesium. Most production at this time still involved platinum, which was used in more applications due to its chemical and physical properties. As it is also highly resistant to acids and heat, platinum was also used to make instruments such as scientific tools, crucibles, and vessels used in chemistry and physics.[14]

As early as the 19th century, platinum had already been used in locking pins to hold false teeth in place. Platinum was also used to make filaments in light bulbs and non-corrosive electrical contacts in telephones. With the development of the tanning lamp in 1904, Küch and Heraeus are regarded as the inventors of the UV high-pressure lamp and pioneers of body irradiation with artificial light sources for medical light therapy. In 1906, Küch developed the standardized resistance thermometer made of platinum, the principle of which is still used today in cars and ovens.[15]

Exposition Universelle (1900)

In 1902, Charles Engelhard (1867-1950), brother-in-law of the two Heraeus brothers, became representative of the group in the USA and founded the Engelhard Corporation, a company for refining platinum, gold and silver. In 1909, Heraeus was transformed from a general partnership into W. C. Heraeus GmbH. Richard Küch became a co-partner and one of three managing directors.[16]

One of the most significant technical innovations in metal processing is credited to Heraeus: the melting of metals under vacuum. Heraeus applied for a patent on this process on 12 January 1918 and was granted a German patent DE 345161.[17] Heraeus was subsequently granted British patent GB 138648, Swiss patent CH 89145, and several French patents on the process. For a short time, Heraeus set up an independent division dedicated to this technology, Heraeus Vacuumschmelze, which registered 84 German patents in 10 years.[18]

1927 – 1945: Further development and setbacks

[edit]

Due to the First World War, hyperinflation in the Weimar Republic and the collapse of the precious metal market in Russia, prices for platinum were subject to extreme fluctuations.[19] Heraeus therefore focused its research activities on recycling techniques, and at the same time tried to find suitable materials to replace the precious metals. At this time, Wilhelm Heinrich Heraeus and his cousin Reinhard Heraeus took over the management of the company in the third generation for almost 40 years from 1927.[19] In this era, new physical findings were implemented by Heraeus – for example in the production of the first dental alloys.[20] Despite the turbulent times, the business continued to grow.[19] By 1939 it employed around 1,000 people, with annual sales of around 20 million ℛ︁ℳ︁.[21]

With the outbreak of the Second World War, numerous workers were drafted into military service. The company employed 1,500 forced laborers from the Hanau civilian labor camp. Production shifted to electrical contacts with low densities of precious metals, catalysts, and rhodium reflectors for armament-related goods such as catalytic converters for anti-aircraft searchlights. During air raids in 1944 and 1945, the company's facilities in Hanau were almost completely destroyed. Heraeus had the company's role in the Third Reich investigated in an independent scientific study at the end of the 1990s and joined the fund of the German business Foundation Remembrance, Responsibility and Future for the compensation of forced laborers.[21]

1945 – 1983: Internationalization after reconstruction

[edit]

During German reconstruction, the company turned its attention back to its established products and expanding new production facilities. The company re-established its network of contacts after the Second World War, allowing it to gain new customers in the American market for quartz glass for optical applications.[22]

Beginning in 1958, the company founded its first sales subsidiaries in France and Italy, followed by full subsidiaries and international holdings as of 1972. The company subsequently set up new quartz glass factories in Japan and the United States, followed by manufacturing facilities in South Korea and the Philippines to produce contact wires (wire bonding) made of pure gold for use in semiconductor components. In 1970, Helmut Gruber, a physicist in the field of metallurgy, took over the management of the company, as well as the responsibility for the technology department across the group. He promoted activities in the field of quartz glass, precious metal chemistry and special metals as well as the establishment of subsidiaries abroad.[23]

Fun facts: Heraeus supplied the space-stable quartz glass for the still functional laser reflector for the exact determination of the distance between Earth and the Moon, which the Apollo 11 mission left behind on the lunar surface.[24]

1983 – 2000: Founding of the holding company

[edit]
A troy ounce of gold with a Heraeus imprint

From 1983 until 2000, Jürgen Heraeus, son of Reinhard Heraeus who was a member of the Board of Management since 1970, headed the company in the fourth generation. Under his management, the business grew into a global group of companies. For this, a far-reaching reorganization of the company took place, as well as new management structures introduced. Following the founding of Heraeus Holding GmbH in 1985, the company underwent a comprehensive decentralization in 1990. Under the umbrella of the management holding, the group's core activities of precious metals, dental materials, quartz glass, sensors and medical technology were reorganized into five decentralized, independent management divisions.[25][26]

In 1991, a hydrogen tank exploded at the quartz glass site in Hanau, destroying large parts of the factory premises.[27] In the same year, the company established a factory for the production of synthetic quartz glass for the manufacture of optical fibers in the chemical park in Bitterfeld-Wolfen (Saxony-Anhalt) after German reunification.[28][29] Simultaneously, the company expanded internationally, especially in Asia. As the company grew, sales and operating profits reflected its standing as an international group.[29][30]

2001 – 2019: Growth and restructuring

[edit]
Jürgen Heraeus, 2017

At the beginning of 2000, Jürgen Heraeus took over as Chairman of the Supervisory Board of the family-owned company. For the first time, the management board did not include a family member.

To exploit synergies throughout the group, Heraeus refocused its activities on core business, leading to further restructuring. The Heraeus Med part of the company was sold in 2002, as were the group's shares in Kendro Laboratory Products.[31][32] At the same time, Heraeus intensified its involvement in industrial precious metals by expanding its activities in the field of thin film materials.[33]

In 2009, the W.C. Heraeus business segment was split into the new Heraeus Precious Metals and Heraeus Materials Technology business units, marking the first major restructuring. In 2013, Heraeus Dental was sold to the Mitsui Group, a Japanese company.[34] The same year, Jan Rinnert, Jürgen Heraeus' son-in-law, took over the company's management. He oversaw another major corporate restructuring in 2015. The existing structure of a holding company overseeing six business units was transformed into a holding company overseeing eleven so-called Global Business Units (GBUs). For this purpose, Heraeus Precious Metals and Heraeus Materials Technology, two of the six existing business units, were dissolved and reorganized into seven GBUs.[35][36][37]

In October 2018, Heraeus extended its sales channels in Germany by opening the online platform Heraeus-Gold.de in co-operation with the precious metals trader Ophirum GmbH. The platform allows retail customers to buy Heraeus precious metal bars and a variety of popular coins.[38]

Since 2020: Acquisitions, sales and investments

[edit]

In 2021, Heraeus acquired the US company Norwood Medical, a manufacturer of medical instruments, devices, and components with more than 1100 employees. The acquisition is considered one of the largest in the company's history.[39] This was followed in 2022 by the acquisition of PET recycling company Perpetual Technologies, which was renamed Revalyu Resources at the same time.[40] Also in 2022, Heraeus founded a joint venture with BASF, with equal shares, to recover precious metals from spent automotive catalysts. The new company, BASF Heraeus Metal Resource, produces recycled precious metals for high-tech industries in China.[41]

In April 2023, Heraeus sold its platinum temperature sensor business (Heraeus Nexensos) to Yageo, an electronic components company.[42] In June 2023, the business portfolio was restructured and the previous division into Global Business Units and Start-ups was replaced by the designation Operating Companies.[3][43]

At the end of 2023, Heraeus sold its specialty lighting business Heraeus Noblelight to the US-based Excelitas Technologies Corp., based in Waltham, Massachusetts.[44]

In June 2024, Heraeus acquired 100% of McCol Metals, a Canadian company specializing in the recovery of iridium from spent mixed metal oxide electrodes.[45]

In 2025, the Chinese Haitian Group acquired Heraeus Photovoltaics (Shanghai), Heraeus Photovoltaic Technology (Shanghai), and Heraeus Photovoltaics Singapore, thereby acquiring the business of photovoltaic silver pastes for approximately 66 million euros.[46]

In May 2025, a leadership change occurred at Heraeus: the previous operational managing director Frank Stietz became the new chairman of the management board. He succeeds Jan Rinnert, who led the family business for twelve years.[47]

Specialty Products

[edit]

Heraeus products are used in metal, electronics, chemistry, automotive, telecommunications or medicine.[48] The group supplies products to manufacturing companies in the automotive industry, the aerospace sector, telecommunications, the chemical industry, medical technology and the steel industry.[36]

A main business unit of the Heraeus Group is the production and processing of precious metals (e.g. platinum, gold, silver). The metals are processed, among other things, into wires or substrates for components in the automotive or electrical industries, or used in sensors that measure, for example, the sulfur content or temperature in the production of steel.[49][50] Another component of the group is quartz glass used in processing for the semiconductor industry, as well as in special preforms for the production of glass fibers.[51][52]

Heraeus produces special light sources in the UV and infrared range; both for industrial use, such as for hardening printing inks and plastics, and for disinfecting drinking water.[53] In the medical sector, Heraeus produces components such as bone cement and coatings for implants, as well as High Potency API.[54][55]

Corporate structure

[edit]

Under the umbrella of Heraeus Holding, the Heraeus Group operates as an international conglomerate of more than 100 individual companies in 40 countries.[5][49] The headquarters and head office are in Hanau, Hesse. The group's four fields of activity are as follows: Metals and Recycling, Healthcare, Semiconductor and Electronics as well as Industrials. The various business activities are divided into 15 operating units, which Heraeus has been calling Operating Companies since 2023.[56]

The Heraeus Holding is wholly owned directly and indirectly by the founding family, with around 200 family shareholders.[57] Jürgen Heraeus and his siblings hold 25 percent of the shares.[58]

Operating companies of the Heraeus Group

[edit]

Sources:[3][43][59]

Metals and Recycling

  • Heraeus Precious Metals: trading, production and recycling of precious metals; manufacture of products for industry (e.g., catalysts for the production of plastics or hydrogen, coatings for PC hard disks, wires for microchips and pacemakers, etc.),
  • Heraeus Amloy: development and production of amorphous alloys and components,
  • Heraeus Remloy: production of neodymium iron boron materials,
  • Revalyu Resources: PET recycling company (majority shareholding).

Healthcare

  • Heraeus Medical: bone cement and coatings for medical implants in surgical orthopedics,
  • Heraeus Medevio (formerly Heraeus Medical Components): Components for the medical technology industry, e.g., pacemaker components and components for the treatment of vascular diseases,
  • Norwood Medical: development and production of instruments, tools, and components in medicine,
  • Mo-Sci: development and manufacturing of precision glass technology, e.g., glass microspheres, powders, ingots, and specialty glasses,
  • Engineered Tissue Solutions: development of medical wound care products composed of proprietary borate-based bioactive glass.

Semiconductor and Electronics

  • Heraeus Electronics: production of miniature electronic components and assembly materials for the electrical and automotive industries (e.g., bonding wires, thick-film pastes, and conductive polymers),
  • Heraeus Epurio: capacitors, displays, photoresists (photoresist), and conductive polymers for the semiconductor industry,
  • Heraeus Covantics: production and processing of high-purity quartz glass and ceramics and novel composites; production of synthetic quartz glass and ceramic materials for the data transmission and telecommunications industry, production of specialty fibers for industrial and medical applications, semiconductor manufacturing and optics,[60]
  • Heraeus Printed Electronics: digital printing process for metallic conductive systems.

Industrials

  • Heraeus Electro-Nite: measurement technology such as (disposable) sensors and samplers specifically for molten metals, as well as hardware and software for systems engineering,
  • Smart Steel Technologies: AI-based software products for the steel manufacturing process (minority shareholding).

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia
from Grokipedia

Heraeus Holding GmbH is a family-owned multinational technology conglomerate headquartered in , , specializing in precious metals processing, glass manufacturing, medical technology, and for semiconductors, , and industrial applications.
The company's origins trace back to a family established in 1660, with its modern foundation in 1851 when Wilhelm Carl Heraeus transformed the business into a precious metals refinery, initially focusing on and .
Over the subsequent decades, Heraeus expanded into high-vacuum technology, specialty , and biomaterials, achieving milestones such as supplying glass components for the mission in 1969 and establishing leadership in synthetic fused silica production for and .
Today, as one of 's largest family-owned enterprises, Heraeus operates globally with businesses spanning metals recycling, healthcare solutions, and sensor technologies, employing over 16,000 people across more than 40 countries while maintaining a commitment to innovation in and sustainability.

History

Origins in pharmacy and early foundations (1660–1850)

The Heraeus family's entrepreneurial roots lie in , beginning in , , during the mid-17th century. The Einhorn-Apotheke, or Unicorn Pharmacy, was acquired by the family in 1660 and formally established by Isaac Heraeus (1636–1676) in 1668 at the Marktplatz in Hanau-Neustadt, where he purchased a half-timbered house and named the establishment "Zum weißen Einhorn." As the son of the pharmacist Dr. Johannes Heraeus, Isaac continued the family's pharmaceutical tradition, which traced back to his father's studies at the . For over two centuries, the Einhorn-Apotheke operated exclusively as the gräfliche Hofapotheke, serving as the official court pharmacy to the counts of and dispensing medicines to the nobility and local populace. This role underscored its stability and prestige within the region's , with operations focused on compounding remedies, sourcing herbal and chemical ingredients, and adhering to the era's pharmaceutical regulations under the . The business passed paternally through six generations of Heraeus pharmacists, maintaining a focus on traditional dispensing without notable diversification until the mid-19th century. By the early , the remained a cornerstone of the family's holdings in , supporting the local economy amid growing industrialization in . Successive Heraeus proprietors, trained in at institutions like the , upheld the enterprise's reputation for reliability, though records indicate no major innovations in pharmaceutical practice during this foundational phase. This period laid the groundwork for the family's later pivot toward chemical processing, as the pharmacy's handling of metals in medicinal preparations foreshadowed industrial applications. The original building endured until its destruction in an Allied air raid in , symbolizing the enduring legacy of these early operations.

Establishment of precious metals operations (1851–1914)

In 1851, Wilhelm Carl Heraeus (1827–1904), a pharmacist and chemist, assumed control of the family-owned Einhorn Pharmacy in Hanau, Germany, from his late father Esay Heraeus, marking the onset of precious metals processing operations alongside traditional pharmaceutical activities. Motivated by the industrial demand for platinum—a metal prized for its corrosion resistance but challenging to melt due to its high melting point of approximately 1,768°C—Heraeus established a small laboratory dedicated to refining and alloying precious metals. This initiative positioned the firm to capitalize on platinum's applications in scientific instruments, dentistry, and electrical contacts. By 1856, Heraeus achieved a breakthrough by inventing a method to melt on an industrial scale using hydrogen-oxygen flames, enabling the production of pure crucibles and other forms that were previously imported or unavailable domestically. This innovation founded the "First German Platinum Smelter," transforming into a viable industrial material and establishing Heraeus as a pioneer in precious metals . Operations soon extended to and silver refining, with the company supplying high-purity metals to jewelers, laboratories, and manufacturers, while maintaining the as its operational base. Annual output grew steadily, reflecting the firm's growing expertise in electrolytic refining and alloy production. Following Wilhelm Carl's death in , his sons Wilhelm and Karl Heraeus took over management, sustaining and expanding the precious metals division through investments in advanced furnaces and purification techniques. Under their , the company scaled up production for emerging sectors like the electrical industry, where platinum's conductivity proved essential. By 1909, Heraeus converted from a to a stock ( auf Aktien), which supported capital accumulation for facility expansions in . Approaching 1914, the firm had emerged as a leading European refiner, processing thousands of kilograms of precious metals annually and exporting globally, underpinned by rigorous quality controls that ensured metal purities exceeding 99.9%.

World War I, interwar expansion, and technological advancements (1914–1932)

During , Heraeus played a key role in Germany's industrial by supplying platinum catalyst gauzes essential for the oxidation of to in the , enabling the production of nitrates for explosives amid Allied blockades on natural imports. The company, already Germany's largest processor by 1914 with a of approximately 400, faced acute raw material shortages following the 1917 , which disrupted supplies from Russia's Ural mines, prompting internal research into alloy substitutes and recycling techniques. Heraeus also advanced osmium-iridium alloys for durable nibs, leveraging its precious metals expertise amid wartime demand for precision components. In the , Heraeus navigated post-war economic turmoil, including , by expanding production in spinnerets—gold-platinum nozzles for (viscose ) manufacturing—which became a significant revenue stream as the grew. By , the workforce had increased to 650 employees, reflecting recovery and diversification beyond wartime dependencies. The company maintained its precious metals focus while branching into and optical , capitalizing on stable demand from institutions despite global economic pressures. Technological advancements centered on vacuum , pioneered by Dr. Wilhelm Rohn, whose 1913 process for high-vacuum melting of was patented in 1918 and led to the 1923 founding of Heraeus-Vakuumschmelze (later VACUUMSCHMELZE). This innovation aimed to produce heat-resistant alloys without relying on scarce precious metals like or , using induction furnaces for processing and enabling applications in emerging fields such as and high-temperature tools. Concurrently, refinements in , originally invented in , supported advancements in UV lamps and precision optics, with improved purity and formability for laboratory ware and mirrors exhibiting superior reflectivity. These developments positioned Heraeus as a leader in specialty materials by 1932, bridging traditional with modern industrial needs.

Nazi era operations, contributions, and post-war accountability (1933–1949)

During the Nazi era, W.C. Heraeus GmbH in continued its core operations in precious metals refining, particularly , which was critical for industrial applications including armaments production such as spark plugs and catalysts used in and military equipment. The company benefited from the regime's economic policies, expanding production to meet wartime demands amid resource shortages, with imports and domestic processing supporting the Reich's needs despite . From around 1939 to 1945, Heraeus employed approximately 300 forced laborers, including foreign workers from occupied territories, as part of the Nazi system's exploitation of coerced labor for essential industries. These workers, drawn into the NS camp system's , contributed to the firm's wartime output under conditions aligned with the regime's "Vernichtung durch Arbeit" policy, enabling Heraeus to sustain operations amid labor shortages. The company's reliance on such labor underscored its integration into the Nazi , where precious metals processing indirectly facilitated military efforts through material supply chains, though specific allocations to armaments remain undocumented in available records. Post-war, following Allied occupation in 1945, Heraeus facilities in faced initial disruptions, including potential dismantling under reparations policies, but production resumed by 1946 as part of broader industrial reconstruction in the U.S. zone. proceedings classified most company leadership as nominal party followers rather than active perpetrators, allowing continuity in with minimal structural accountability; this reflected the Allies' pragmatic shift toward economic recovery over exhaustive purges by 1948. By 1949, as the formed, Heraeus operated without formal restitution for forced laborers, with systemic leniency toward industrial firms prioritizing West German stabilization over immediate victim compensation.

Reconstruction, internationalization, and diversification (1950–1989)

Following the devastation of , which left Heraeus's facilities in nearly destroyed, the company rapidly rebuilt its operations in precious metals processing and related technologies. By 1951, the workforce had recovered to approximately 1,000 employees, enabling resumption of core activities such as and production. This reconstruction was supported by investments in new production methods, including the development of arc and electron-beam furnaces for high-purity metal melting, which enhanced capabilities in specialty materials. By 1957, employment had expanded to 3,000, reflecting Germany's broader and Heraeus's focus on domestic recovery before broader diversification. Diversification accelerated in the 1960s and 1970s as Heraeus ventured beyond traditional precious metals into laboratory and medical equipment. In 1969, the company acquired a group of laboratory equipment manufacturers, marking entry into scientific instrumentation and broadening revenue streams. By 1978, innovations included advanced incubator technology for medical and biological applications, supporting growth in healthcare-related products. Turnover reached DM 100 million by 1960 and climbed to DM 2.4 billion by 1980, with 6,300 employees, as segments like quartz glass and sensors gained prominence. Further expansion into measurement systems and catalytic converters occurred by the late 1980s, reducing reliance on volatile precious metals markets. Internationalization began in earnest in 1958 with the establishment of subsidiaries in and , facilitating exports of refined metals and . This was followed by entities in and the in 1964, enhancing European distribution networks. By 1980, acquisitions such as Cermalloy in the United States expanded thick-film materials production, while Pacific Platers Ltd. in (renamed Heraeus Ltd. in 1982) strengthened Asian presence in plating technologies. In 1985, Heraeus Holding was formed to oversee global operations, coinciding with new quartz glass factories in and the . Late-decade moves included the 1988 acquisitions of Electro-Nite International in for sensors and Cooper Laser-Sonics's surgical laser division in the , alongside joint ventures in , , and . Under Chairman Heraeus by 1989, overseas sales constituted 63% of total turnover (DM 4.6 billion), with foreign employees rising to 28% of the 9,300 workforce.

Holding structure, growth, and strategic shifts (1990–2019)

In the early 1990s, Heraeus underwent significant organizational restructuring to enhance and strategic focus. Effective January 1, 1990, the group was divided into five independent operating divisions: Heraeus Instruments (accounting for 30% of 1989 sales), W.C. Heraeus (22%), Heraeus Electro-Nite (21%), Heraeus Quarzglas (17%), and Heraeus Kulzer (10%). This structure, overseen by Heraeus Holding —established in as the central holding entity providing group-wide leadership—was designed to promote autonomy while maintaining family ownership control. In 1992, the formation of Heraeus Noblelight further diversified operations into specialty lighting systems, including and technologies, supporting growth in industrial applications. Growth accelerated through targeted acquisitions and international expansion during the decade. In 1995, Heraeus acquired AG's dental division, elevating Heraeus Kulzer to the third-largest global dental materials provider and bolstering the medical technology segment. By 2001, group sales had reached €6.83 billion (approximately $6.06 billion), with the workforce expanding to 9,100 employees, 30% of whom were based abroad, reflecting overseas sales contributions rising to over 60%. Earlier international momentum included new quartz glass facilities in and the established in 1985, which supported sustained revenue increases from DM 2.4 billion in 1980 to record levels of €7.8 billion by 2000. Strategic shifts in the and emphasized amid market changes. In 1999, Heraeus Instruments merged with Sorvall Products to create Kendro Laboratory Products, with Heraeus retaining a 40% stake to refocus resources on core competencies. The 2001 spin-off of the fiber-optic glass division into Heraeus Tenevo aimed at unlocking value through potential IPO, while maintaining emphasis on high-tech materials. Later, in 2013, the dental business was sold to Japan's Chemicals, streamlining operations away from commoditized segments. By 2015, further consolidated the prior six business units into four focused areas—precious metals, medical technology, , and quartz glass—to enhance agility and innovation alignment. These moves supported continued expansion, with overseas sales reaching 64% of total revenue by the late .

Recent developments, acquisitions, and adaptations (2020–present)

In 2021, Heraeus expanded its medical technology portfolio through the acquisition of Norwood Medical, a U.S.-based manufacturer of precision medical instruments employing over 1,100 people across facilities in , , and . That same year, the company acquired Mo-Sci Corporation, a provider of specialty for medical applications, and ETS Technology Holdings, specializing in glass-based wound care technologies, to bolster capabilities in healthcare materials. In May 2022, Heraeus took a majority stake in perPETual Technologies, a PET bottle recycling firm, subsequently renaming it revalyu Resources to advance initiatives in plastics processing. Strategic divestitures marked adaptations to focus on core competencies. In October 2022, Heraeus agreed to sell its Nexensos subsidiary, a producer of high-end temperature sensors, to Corporation for €79.4 million, with the transaction completing in early 2023 to streamline offerings. In 2023, the company sold its Noblelight specialty lighting business, including UV and technologies, to Excelitas Technologies, finalizing the deal in January 2024 to concentrate resources on precious metals and medtech segments. In June 2024, Heraeus Precious Metals acquired McCol Metals, a Canadian firm specializing in recovery from spent electrodes, enhancing expertise for critical raw materials used in and . Advancing , Heraeus committed to carbon neutrality in select applications by 2025 and net-zero emissions group-wide by 2033, while achieving milestones in its 2025 vision for revenue growth and operational efficiency. In 2025, Heraeus acquired Synthecure® technology from Austin Medical , expanding bioresorbable implant solutions. Recent innovations include the 2025 launch of heracure, a line of resorbable biomaterials for orthopedic regeneration, debuted at the German Congress of Orthopedics and Trauma Surgery (DKOU). Leadership transitioned in May 2025 with Dr. Frank Stietz appointed as CEO and Chairman, succeeding prior executives to guide ongoing internationalization and R&D focus. These moves reflect adaptations to , regulatory demands in medtech, and demand for sustainable materials amid volatile precious metals markets.

Business Segments

Precious Metals Processing and Trading


Heraeus Precious Metals, a division of the Heraeus Group, specializes in the , , processing, and trading of all eight precious metals: , silver, , , , , , and . It is recognized as the world's largest recycler and refiner of these metals, recovering them from end-of-life materials such as industrial catalysts and electronic . The division supplies refined precious metals in forms including bars, powders, and alloys for applications in automotive catalysts, chemical processes, semiconductors, pharmaceuticals, , and jewelry.
In trading, Heraeus Precious Metals leads in industrial transactions, facilitating the purchase and sale of gold, silver, and platinum group metals through platforms like myHeraeus.com, weight accounts, and global transfers, while offering price risk management and financing services. The division maintains five dedicated trading sites to ensure coverage across key time zones. Its subsidiary, Argor-Heraeus in Switzerland—acquired in 2017—produces London Bullion Market Association (LBMA)-accredited Good Delivery gold and silver bars and serves over 50 countries, processing more than 400 tons of gold annually without relying on mining sources. Processing and refining operations span 15 production and recycling sites worldwide, supported by a network of 16 locations across , , , , and . Between 2018 and 2026, the division invested €300 million to expand refining and capacities in , , and , including a €35 million upgrade in , , in 2023 to enhance metals . These efforts underscore Heraeus's focus on sustainable recovery, with operations at eight global sites emphasizing efficient extraction from secondary sources.

Medical Technology and Healthcare Solutions

Heraeus engages in medical technology through subsidiaries focused on orthopaedics, dental solutions, and manufacturing. Heraeus Medical develops s and biomaterials primarily for joint and , enabling the fixation of implants and of infections. The company's PALACOS has been utilized in over 40 million surgeries worldwide since its introduction. These products include antibiotic-loaded variants for infection prevention, mixing systems like PALABOWL, and preformed spacers such as PALACOS, supporting procedures in , , and spinal applications. In dental healthcare, Heraeus operates via Kulzer, providing materials for restorative, prosthetic, and aesthetic . Kulzer's portfolio encompasses composites like Venus Pearl for direct restorations, impression materials, and denture acrylics under the Pala brand, alongside digital solutions for laboratory workflows. These offerings address conservative , , and prosthetics, with products designed for precision and in clinical and lab settings. Heraeus Medevio supports the development and production of advanced medical devices as a , leveraging expertise in for , , and vascular applications. This includes design, prototyping, and scaling for OEM partners, emphasizing and efficiency to accelerate device market entry. In , Heraeus acquired Mo-Sci Corporation to enhance its capabilities in for regenerative medical technologies, expanding biomaterials for and . With over 450 employees in Heraeus Medical alone and distribution in more than 90 countries, these segments prioritize evidence-based innovations to improve surgical outcomes and patient mobility. The focus remains on high-quality, verifiable performance metrics, such as reduced revision rates in cemented arthroplasties, derived from clinical usage data.

Electronics, Sensors, and Semiconductor Materials

Heraeus , a business unit of the Heraeus Group, specializes in developing and manufacturing materials for electronics packaging and assembly, with a strong emphasis on advanced packaging and applications. The division supplies components such as bonding wires, materials, sinter materials, thick film pastes, adhesives, die top systems, and metal substrates, enabling reliable connections in high-performance devices. These materials support higher power density, enhanced durability under extreme conditions, and reduced development cycles for customers in automotive, , and industrial sectors. In materials, Heraeus focuses on technologies as alternatives to traditional , which improve thermal management and reliability in power semiconductors. For instance, their sinter materials facilitate on sintered devices, offering flexibility and performance gains in inverters and . The company also produces thick film materials for circuit printing and substrates that withstand high temperatures and mechanical stress. In , Heraeus invested multi-million euros in Compound Semiconductor (Xiamen) Technology Co. (CSMH), a supplier of premium (GaN) and (SiC) epitaxial wafers, to bolster next-generation capabilities amid growing demand for efficient . Heraeus maintains expertise in sensor technologies, particularly platinum thin-film resistance detectors (RTDs) like Pt100 elements, which provide high accuracy, long-term stability, and low drift across wide ranges from -70°C to +500°C. These s, often in formats such as M-series chips or housings, are used in life sciences, process technology, and industrial monitoring for precise measurements in harsh environments. Additionally, through Heraeus Electro-Nite, the group offers specialized s for molten metal processes, including probes for , oxygen, , and carbon analysis in , aluminum, and operations, enhancing process control and quality.

Quartz Glass and Specialty Materials

Heraeus Covantics, a key division within the Heraeus Group, leads in the production of high-purity quartz glass and fused silica materials, offering customized solutions for semiconductors, , and . These materials are manufactured as semi-finished products, components, and tailored systems, emphasizing low inclusion levels and bubble-free clarity to meet stringent industry demands. Natural quartz glass is derived from melting high-purity sand, while synthetic variants achieve superior purity through processes. Synthetic glass production at Heraeus commenced in 1955, establishing benchmarks for UV transparency and material purity that surpassed contemporaries. By 1992, the company expanded with a dedicated synthetic facility in , enhancing capacity for and chemical applications. Over a century of expertise has enabled Heraeus to supply diverse grades, including those resistant to UV and optimized for high-temperature environments. The Suprasil® brand exemplifies Heraeus's offerings, featuring 3D optically isotropic fused silica free of inclusions, with variants like Suprasil 311 and 312 tailored for UV , , beam splitters, and high-energy lasers. These materials exhibit densities of 2.20 g/cm³, low coefficients (approximately 0.55 × 10⁻⁶ K⁻¹), softening points around 1665°C, and transmission from deep UV (below 200 nm) to near-infrared, alongside high . Heraeus also produces HLQ-170 for ultra-high-pressure lamps, providing enhanced durability under intense conditions. Applications span fiber optics—where Heraeus supplied fused silica for transatlantic cables since 1993—medical devices, environmental sensors, and processing equipment. Innovations include AI-driven quality detection for defect-free production and expansions announced in January 2025 to bolster global supply chains. Heraeus's quartz solutions prioritize exceeding 99.999% SiO₂, enabling reliability in high-stakes environments like space reflectors and VUV lamps.

Research, Development, and Innovation

Key Patents and Technological Breakthroughs

Heraeus achieved a foundational breakthrough in materials science in 1899 with the fusion of rock crystal into high-grade vitreous silica, or quartz glass, using an oxygen-hydrogen burner, enabling the production of bubble-free, high-purity quartz for optical and industrial applications. This innovation, refined by Dr. Richard Küch through an oxyhydrogen gas blowpipe process, established Heraeus as a leader in synthetic quartz glass manufacturing, critical for semiconductors, fiber optics, and high-temperature components. In medical technology, Heraeus patented a heat-curing molding compound in 1936, laying the groundwork for PALACOS , which has been refined over decades for orthopedic applications like spacers and management. Key advancements include patents for femoral spacers with integrated devices (US11109977B2, 2021) and methods for producing customizable spacers using casting molds (US11998451B2, 2024), enhancing surgical outcomes in revision procedures. These developments prioritize and mechanical stability, supported by clinical data on reduced rates. For electronics and semiconductors, Heraeus defended a critical patent on metal sintering technology in 2024, covering silver-based sintering pastes like mAgic PE360 for reliable, high-temperature connections in power electronics, reducing voids and improving thermal conductivity over traditional soldering. Additional patents include methods for joining components via sintering (US8950652B2, 2015) and additive manufacturing of refractory metal moldings using niobium and tungsten powders (granted September 2024), advancing efficiency in semiconductor fabrication. In 2023, Heraeus licensed Bosch's portfolio for inorganic potting compounds, accelerating innovations in encapsulating sensitive electronics. In precious metals processing, patents focus on recovery and , such as a 2024 method for extracting s from waste catalysts (US12442058B2) and conductive pastes for solar cells and electronics (US10784383B2, 2020), optimizing electrical performance with inorganic reaction systems. Heraeus also developed industrial catalysts for lignin conversion, improving yields through efficient . Recent quartz glass innovations include AI-driven defect detection for meter-long cylinders (implemented 2023) and hollow-core fiber technology scaled with for AI data transmission, leveraging Heraeus's century-old expertise in high-purity materials. These patents and breakthroughs underscore Heraeus's emphasis on precision , with over 40 filings in materials alone by 2024.

R&D Investments and Focus Areas

Heraeus allocates approximately 6% of its annual revenue to , supporting innovation across its business segments. In 2023, total R&D expenditure reached €172.9 million, up from €155.8 million in 2022, reflecting sustained commitment amid economic challenges. The company employs more than 940 personnel dedicated to R&D activities, contributing to over 1,100 families worldwide. In the Precious Metals segment, R&D emphasizes electrocatalysts for and fuel cells, including the development of a stable ruthenium-based catalyst for water to mitigate reliance on scarce . Efforts also target and , with expanded collaborations and investments in production capabilities, such as new facilities in , . The & Electronics division focuses on advanced packaging solutions, integrated circuits, and materials for solar photovoltaics, including paste formulations and upgrades to enhance efficiency. Heraeus has doubled R&D investments in solar-related technologies in recent years, alongside battery innovations for mobility and to align with regulatory shifts like the EU's 2035 combustion engine phase-out. Healthcare R&D centers on engineering and materials, with interdisciplinary projects advancing product prototyping and . In Specialty Materials, efforts prioritize quartz glass applications and industrial catalysts for environmental processes. Globally, Heraeus has boosted R&D infrastructure in , establishing innovation centers to foster partnerships in semiconductors and .

Corporate Governance and Structure

Family Ownership and Succession

Heraeus Holding remains wholly owned by the descendants of founder Wilhelm Carl Heraeus (1827–1904), with ownership distributed among approximately 200 family s spanning multiple generations and organized into two primary family branches that collectively control 96% of the group. This structure, preserved through direct and indirect holdings, emphasizes long-term independence and strategic continuity, distinguishing Heraeus from publicly traded peers. To manage succession in a broadly distributed family enterprise, Heraeus employs a shareholders' committee alongside a that integrates family representatives with external expertise. Jürgen Heraeus, a great-grandson of the founder and former operational leader from 1983 to 2000, chaired the for 20 years until stepping down around 2020, facilitating a transition that included family continuity via his daughter Birgit Heraeus-Roggendorf's role on the board. In executive management, the family reintroduced direct involvement with Jan Rinnert—Jürgen Heraeus's son-in-law and a —serving as CEO and board chairman from July 2013 to May 2025, the first such family-led operational role since 2000, before yielding to professional manager Frank Stietz. This hybrid model of family oversight and merit-based operational leadership addresses common challenges in multi-generational family firms, such as diluting influence and aligning diverse interests, while prioritizing the company's technological focus over short-term gains.

Organizational Framework and Subsidiaries

Heraeus Holding serves as the parent entity of the Heraeus Group, functioning as a family-controlled conglomerate that oversees more than 100 individual companies operating in over 40 countries. This decentralized structure allows for operational autonomy within subsidiaries while maintaining centralized strategic oversight through integrated management platforms that incorporate business, financial, and considerations. The group's framework emphasizes technological expertise across , with decision-making aligned to long-term innovation rather than short-term market fluctuations. The organizational model is segmented into four primary business platforms—Metals & , Healthcare, & , and Industrials—which bundle diverse activities and subsidiaries focused on precious metals processing, medical components, electronic materials, and quartz glass applications, respectively. These platforms operate as semi-independent units, enabling targeted investments and regional adaptations, supported by a global network of 121 locations as of 2023. Notable subsidiaries exemplify this setup, including Heraeus Precious Metals & Co. KG, which handles refining and trading of noble metals; Heraeus Medical , specializing in orthopedic and dental biomaterials; and Heraeus Electro-Nite International N.V., focused on sensors for molten metals in and aluminum industries. Additional entities, such as Heraeus and Heraeus Covantics under the Semiconductor & platform, develop thick-film pastes and , reflecting the group's emphasis on specialized technological niches. This portfolio, totaling over 100 entities, facilitates risk diversification and market expansion without direct reliance on equity markets.

Leadership and Management

The Heraeus Group operates under a two-tier structure consisting of a Board of Managing Directors responsible for operational management and a providing oversight and strategic guidance. This framework aligns with standard practices for large German family-owned enterprises, ensuring separation between executive decision-making and shareholder representation. As of May 2025, Dr. Frank Stietz serves as CEO and Chairman of the Board of Managing Directors, having succeeded Jan Rinnert in this role. Stietz, previously COO and a long-term executive within the group, leads a board that includes Dr. Steffen Metzger (Precious Metals), Dr. Klemens Brunner ( & / Industrials), and Heiko Specht (Healthcare). The Group Executive Leadership Team supports these directors with specialized functions, comprising Dr. Martina Gieg (), Helge Heindl (), Nadine Jacobi (), Deniz Serifsoy (Chief Transformation Officer), and Helena Hallwas (Head of Corporate Audit, as permanent guest). The Supervisory Board, chaired by Franz Haniel since succeeding Jürgen Heraeus around 2020, includes family representation through members like Birgit Heraeus-Roggendorf alongside independent experts such as Dr. Simone Bagel-Trah and Dr. Hubert Lienhard. Haniel's appointment reflects a transition toward external professional oversight while maintaining family influence, as over 200 Heraeus family shareholders hold approximately 96% ownership. This structure balances generational continuity—spanning from founder Wilhelm Carl Heraeus in 1851 to the present—with merit-based executive appointments, minimizing direct family control over day-to-day operations.

Financial Performance and Economic Impact

Revenue Streams and Key Metrics

The Heraeus Group's revenue primarily derives from four business areas: Metals & Recycling, Healthcare, Semiconductor & Electronics, and Industrials. The Metals & Recycling area, encompassing precious metals trading, refining, and recycling, accounts for the majority of total revenue owing to high-volume transactions tied to global commodity prices, though these figures are volatile and exclude value-added processing margins. The remaining segments generate revenue from specialized products such as medical implants and biomaterials (Healthcare), components for semiconductors and electronics (Semiconductor & Electronics), and quartz glass, ceramics, and industrial materials (Industrials), which emphasize technological applications over commodity volumes. To assess operational performance independent of precious metals price swings, Heraeus reports excluding precious metals, which in totaled €2.9 billion, distributed across segments as follows: Healthcare (€782 million), Industrials (€759 million), & (€687 million), and others including environmental technologies (€667 million). This metric underscores the company's focus on high-margin, innovation-driven sales in non-commodity areas, with growth in driven by demand in and sectors amid and expansions. Key financial metrics for recent years highlight revenue growth alongside profitability measures:
Metric202420232022
(€ billion)29.425.629.1
Revenue ex. Precious Metals (€ billion)Not reportedNot reported2.9
Profit After Taxes (€ million)Not reported444499
Employees (year-end)~16,400~16,40015,938
Total revenue increased 14.6% from 2023 to 2024, reflecting higher precious metals activity, while employee headcount has stabilized around 16,000 across 40 countries. EBITDA stood at €949 million in 2022, with EBIT at €688 million, indicating robust margins on non-precious metals operations despite total revenue fluctuations.

Growth Drivers and Challenges

Heraeus has achieved notable revenue expansion, with total group revenue reaching €29.4 billion in 2024, marking a 14.6% increase from €25.6 billion in 2023, driven primarily by robust demand in its Semiconductor & Electronics and Healthcare business platforms. The Semiconductor & Electronics segment benefits from rising global needs for , including powders and glass used in chip manufacturing and processes. In Healthcare, growth stems from specialized products for medical devices and implants, with the company projecting strong revenue increases in this area amid aging populations and technological advancements in treatments. Strategic investments in innovation and regional expansion further support , such as the establishment of an innovation lab in to address local customer needs in and faster response to market trends. Heraeus also leverages its leadership in precious metals refining and recycling, capitalizing on industrial demand for metals in applications like systems and , while pursuing sustainability initiatives to enhance long-term competitiveness. Key challenges include volatility in precious metals prices, which significantly influences overall revenue given the segment's scale; for instance, fluctuations in and markets can offset gains in stable areas, as seen in Scope 3 emissions rising 6% in 2023 due to increased purchases. Intense and delays in customer product development have eroded demand in certain electronics subsectors, compounded by cost pressures. Supply chain disruptions and geopolitical tensions add risks to materials sourcing, while regulatory scrutiny on environmental impacts in metals demands ongoing investments to mitigate compliance costs.

Controversies and Criticisms

World War II-Era Involvement and Forced Labor

During , W.C. Heraeus in operated as part of the Nazi regime's , producing precious metals, , and related components vital for applications such as , , and armaments. The company expanded its workforce to meet production demands, incorporating foreign laborers under coercive conditions mandated by German authorities, including the 1938 decree on foreign worker recruitment and subsequent expansions via the Reich Labor Service. This alignment with the Wehrwirtschaft—Hitler's militarized economy—enabled Heraeus to sustain output amid labor shortages, processing materials like and that supported industrial and possibly plundered resource chains, though direct handling of looted assets remains less documented compared to peers like Degussa. Heraeus employed approximately 1,500 forced laborers drawn from the Zivilarbeiterlager , a designated established for coerced foreign workers, primarily civilians from occupied and other regions. These individuals, classified under Nazi categories like (Eastern workers) or civilian auxiliaries, originated from at least seven countries, including , the , and others in occupied territories, subjected to rations below subsistence levels, restricted movement, and punitive oversight typical of the regime's exploitative system. Operations involved hazardous tasks in metal refining and fabrication, contributing to Heraeus's wartime profitability amid the broader German industrial reliance on an estimated 7.6 million foreign forced laborers by 1944. Postwar scrutiny prompted Heraeus to contribute to the German Foundation "Remembrance, Responsibility and Future" established in , which disbursed over €5 billion in compensation to surviving forced laborers from Nazi-era exploitation, with participating firms like Heraeus acknowledging without admitting . In the late , the company commissioned independent historical research, including works documenting its integration into NS-era production and labor practices, revealing no evidence of resistance to directives but yielding economic gains. This era's legacy underscores systemic corporate adaptation to authoritarian demands, where precious metals firms processed wartime resources—potentially including gold from occupied nations—prioritizing output over ethical constraints.

Environmental and Labor Practices

Heraeus has established goals aimed at reducing its environmental impact, including a commitment to carbon neutrality in its own operations by 2025 and a 42% reduction in Scope 1 and 2 emissions by 2030 relative to the 2021 baseline. The company reports progress through measures such as , which it claims reduces its CO2 footprint by up to 98% in certain processes, and investments in emission catalysts for industrial applications. However, Heraeus subsidiaries have incurred penalties for environmental non-compliance, including violations totaling $62,500 across four incidents, such as a $26,000 fine in 2009 for violations under the Clean Air Act and a $6,500 penalty in 2001. In 2009, Heraeus Metal Processing Inc. also pled guilty to falsifying Clean Air Act information, resulting in additional fines. Hazardous waste violations have further contributed to regulatory actions, including a 2013 consent order addressing non-compliance with health and safety codes. Subsidiary Argor-Heraeus has faced criticism for sourcing from gold mines linked to , as highlighted in a 2023 Human Rights Watch report on Ethiopian operations where refiners, including Argor-Heraeus, were accused of overlooking environmental damage despite awareness; the company denied the allegations. Heraeus maintains due diligence policies aligned with guidelines to mitigate risks of environmental harm in upstream , emphasizing avoidance of conflict zones and pollution-intensive sources. On labor practices, Heraeus policies prohibit forced labor, child labor, and , committing to fair wages and reasonable working hours in line with ILO conventions, with supplier codes extending these standards across its value chain. The company reports no tolerance for such practices and implements mechanisms like the Heraeus SpeakUp for reporting violations. Despite these commitments, Heraeus has faced workplace and violations, accruing $91,978 in penalties over six incidents tracked by regulatory databases. Individual employee complaints, such as those in a 2019 alleging mishandling of workplace s at a , indicate occasional disputes over internal handling of issues, though outcomes varied without systemic patterns emerging in public records. In supply chains, particularly precious metals sourcing, Heraeus acknowledges risks of labor abuses in but relies on audits and certifications to enforce compliance, without documented direct involvement in modern forced labor cases.

Market and Regulatory Scrutiny

In September 2019, the U.S. (CFTC) fined Heraeus Metals New York LLC $900,000 for engaging in spoofing in precious metals futures contracts on the and COMEX. The violations involved a trader placing large-volume orders with the intent to cancel them before execution, thereby creating a false impression of market demand or supply between May 2017 and January 2018; the trader, John Lawrence, was separately fined $130,000 and suspended from trading for four months. In January 2014, the U.S. Department of Justice (DOJ) filed a civil antitrust against Heraeus Electro-Nite Co., LLC, requiring the divestiture of assets acquired from Midwest Instrument Co., Inc. (Minco) in an unreported merger consummated in 2012. The transaction threatened to reduce in the U.S. market for single-use sensors and instruments used to measure , oxygen, and other properties in molten , where Heraeus held approximately 85% prior to the deal; the DOJ settlement mandated asset sales to an independent buyer to restore . In 2009, the German Federal Cartel Office conducted an antitrust investigation into Heraeus Kulzer GmbH concerning potential in the dental materials sector but ultimately closed the probe without issuing charges or penalties. Subsidiary Argor-Heraeus S.A., a Swiss precious metals refiner, has faced heightened regulatory and legal scrutiny over due , including a 2016 alleging it refined nearly three tons of looted from the of Congo by armed groups between 2004 and 2005, amid broader international pressure on refiners to verify origins and combat illicit trade.

References

Add your contribution
Related Hubs
User Avatar
No comments yet.